Latest Ludwig Cancer Research News

Nanosensors for early detection of lung cancer
Ludwig Cancer Research statement on COVID-19
Targeting turncoat immune cells to treat cancer
Dismantling drug resistance in colorectal cancer
Building a safer CAR-T therapy
Robert Schreiber joins Ludwig Institute’s Scientific Advisory Committee
A single number to mark deadliest cancer cells
Douglas Hanahan appointed Distinguished Scholar of Ludwig Institute for Cancer Research
Ping-Chih Ho appointed Associate Member of Ludwig Institute for Cancer Research
Vaccitech Oncology Limited and Ludwig Institute for Cancer Research enter collaboration with Cancer
Ludwig researchers engineer car-t cells to resist exhaustion, attack solid tumors in mice
Ludwig Lausanne’s Ping-Chih Ho named an embo young investigator
A new pathway for lung cancer treatment
Ludwig Harvard study reveals how non-mutational changes to genome drive a type of cancer
Ludwig researchers develop machine learning tool to refine personalized immunotherapy
Ludwig Oxford’s Sir Peter Ratcliffe wins Nobel Prize
Aggressive brain cancers tap into neural wiring to thrive
Alexandra Johnson appointed to Board of Ludwig Institute for Cancer Research
Test promises to improve identification of precancerous pancreatic cysts
Ludwig study establishes cancer-driving role of enzyme that alters membrane of cancer cells
Ludwig Stanford researchers borrow from sports playbook to predict cancer outcomes